For instance, it has been observed that the estrogen receptor (ER) inhibits the expression of the miR-221/222 genes in breast cancer, while in the progression of PCa, miR-125b, miR-21, and miR-221/222 could be directly regulated by the androgen receptor (AR) [38]. This evidence concerns the gene ESR1 and breast carcinoma.